SMARTREND NEWS & MARKET ANALYSIS
SmarTrend analyzes over 5,000 stocks simultaneously on an intraday basis using its pattern recognition technology to give you real-time alerts for stocks on the move -- so you can maximize your trading results. Let our system increase your market awareness.
News Watch
AMAG Pharma Jumps on Low Adverse Event Rate for Anemia Drug (AMAG) - 2/8/2010 9:22:15 AM

2/8/2010-Shares of AMAG Pharmaceuticals (NASDAQ:AMAG) are trading 6.4% higher to $40.19 premarket Monday after the company , responding to safety concerns expressed by an analyst, said serious adverse events had been reported in 0.1% of patients using the company's anemia drug, Feraheme, since sales began in July.


SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html



 



Comtex News Network, Inc. is not a registered investment advisor and does not provide investment advice.
Copyright Comtex News Network, Inc